Inventor · disambiguated record
Megumi Maruyama
Also filed as: MARUYAMA MEGUMI
8 granted patents·9 pending applications·90 citations·filing 2009–2024
86Inventor score
Files withBOEHRINGER INGELHEIM INT9SUNOVION PHARMACEUTICALS INC4DAINIPPON SUMITOMO PHARMA CO1FRIEDL THOMAS1MARUYAMA MEGUMI1
Top patents by PatentIndex Score
17 records- 0196US9415016B2DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2015·Granted Aug 16, 2016·30 cites·27 claims
- 0295US10973827B2DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2019·Granted Apr 13, 2021·9 cites·10 claims
- 0393US9155705B2DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationFRIEDL THOMAS·Filed 2009·Granted Oct 13, 2015·42 cites·25 claims
- 0492US11654113B2Modified release formulations and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2021·Granted May 23, 2023·3 cites·24 claims
- 0592US11160758B2Modified release formulations and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Nov 2, 2021·6 cites·29 claims
- 0689US2024307403A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0786US2023338386A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0882US2022378797A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0976US2021196722A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1075US12161758B2Modified release formulations and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·0 cites·34 claims
- 1167US2018289716A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1265US10022379B2DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jul 17, 2018·0 cites·20 claims
- 1362US2016310435A1Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparationBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1455US2024100022A1Oral solid preparationSUMITOMO PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1548US2022323409A1Modified release formulations and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1637US2011003994A1Cycloalkane derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2010·Application pending·0 cites
- 1724US8541585B2N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereofMARUYAMA MEGUMI·Filed 2011·Granted Sep 24, 2013·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Megumi Maruyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →